Trial Details

COMPLETED
Basic Information
Clinical ID c1476
Identifier NCT04987333
Trial Title Study of Efavaleukin Alfa in Healthy Chinese, Japanese, and Caucasian Participants
Trial URL Visit Original Page
Study Information
Study Results

YES
Conditions Inflammatory Diseases
Interventions DRUG: Efavaleukin alfa
Participant Information
Sponsor Amgen
City LDS
Country/Region United Kingdom
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE1
Time Information
Start Date 2021-08-09
Primary Completion Date 2022-10-03
Completion Date 2022-10-03